Systematic Immunotherapy Target Discovery Using Genome-Scale In Vivo CRISPR Screens in CD8 T CellsMatthew B. Dong, Sidi Chen, Paul Renauer et al.|Cell|2019Cited by 326
In vivo CRISPR screening in CD8 T cells with AAV–Sleeping Beauty hybrid vectors identifies membrane targets for improving immunotherapy for glioblastomaLupeng Ye, Sidi Chen, Jonathan J. Park et al.|Nature Biotechnology|2019Cited by 205
Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNAShuai Yuan, Yong Xiong, Lei Peng et al.|Molecular Cell|2020Cited by 203
A genome-scale gain-of-function CRISPR screen in CD8 T cells identifies proline metabolism as a means to enhance CAR-T therapyLupeng Ye, Sidi Chen, Jonathan J. Park et al.|Cell Metabolism|2022Cited by 190
One-step generation of modular CAR-T cells with AAV–Cpf1Xiaoyun Dai, Sidi Chen, Jonathan J. Park et al.|Nature Methods|2019Cited by 168